Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.9301 +0.0227 (+2.50%)
Streaming Delayed Price Updated: 10:01 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
33 34 Next >
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money
Not every stock on the popular trading app is worth owning. 
Via The Motley Fool
Vaccine Victory
Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson... 
Via Talk Markets
Topics Economy
Exposures COVID-19 Interest Rates Product Safety
Cynicism and Conspiracy Theories Could Help Ocugen
While OCGN stock seems well behind the vaccination race to be worth a shot, there is one narrative that could potentially help. 
Via InvestorPlace
Exposures COVID-19
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the... 
Via Talk Markets
Exposures Product Safety
Analyzing Ocugen's Unusual Options Activity
On Wednesday, shares of Ocugen (NASDAQ:OCGN) saw unusual ... 
Via Benzinga
Ocugen’s Facing a Major Uphill Climb Without FDA Approval
OCGN stock will be hard pressed to push any higher in the absence of good news 
Via InvestorPlace
Exposures Product Safety
Ocugen Stock Is Well-Positioned, But Investors Want Results
The company's latest business update sounds all fine and good, but OCGN stock holders want to see some action, not just words. 
Via InvestorPlace
Exposures COVID-19
Ocugen Stock Still Looks Poised to Tumble
Ocugen's apparent failure to prepare a U.S. trial for Covaxin, which will likely be necessary for FDA approval, bodes badly for OCGN stock. 
Via InvestorPlace
Exposures Product Safety
Ocugen Stock Remains an All or Nothing Wager You Shouldn’t Make
With limited upside from both its booster shot and Canada EUA catalysts, it's still best to avoid/sell OCGN stock. 
Via InvestorPlace
Exposures COVID-19
Analyzing Ocugen's Unusual Options Activity
Ocugen (NASDAQ:OCGN) shares experienced unusual options activity on Thursday. The stock price moved down to $6.92 following the option alert. Sentiment: BULLISH Option Type:... 
Via Benzinga
LAWSUITS FILED AGAINST OCGN, DKNG and PLL - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
CLASS ACTION UPDATE for OCGN, HMPT and ARDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / August 16, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
Exposures Financial Legal Product Safety
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, OCGN and OTLY
NEW YORK, NY / ACCESSWIRE / August 16, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Exposures Product Safety
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, AHCO and ATVI
NEW YORK, NY / ACCESSWIRE / August 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Exposures Product Safety
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ocugen, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
LAWSUITS FILED AGAINST OCGN, DKNG and BZ - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / August 13, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Ocugen Now Relies Solely on A Continued COVID-19 Crisis
OCGN stock is a mix of irrational exuberance related to its valuation, unrealistic hopes, continuous speculation and very poor fundamentals. 
Via InvestorPlace
Exposures COVID-19
CLASS ACTION UPDATE for OCGN, REKR and BLCT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / August 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
Exposures Financial Legal Product Safety
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
From The Law Offices of Frank R. Cruz
Via Business Wire
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, BLCT and OTLY
NEW YORK, NY / ACCESSWIRE / August 13, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
SHAREHOLDER ALERT: OCGN BZ PLL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / August 12, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud
Exposures Legal Product Safety
Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links
The European Medicines Agency is investing a possible link between mRNA vaccines and erythema multiforme or two kidney disorders by a few recipients of the shots.... 
Via Benzinga
Exposures COVID-19
CLASS ACTION UPDATE for OCGN, RKT and BZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
Exposures Financial Legal Product Safety
OCGN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SHAREHOLDER ALERT: OCGN DKNG OTLY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / August 11, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud
Exposures Legal Product Safety
Lawsuits Filed Against OCGN, CRMD and ARDX - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / August 11, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, CRMD and AHCO
NEW YORK, NY / ACCESSWIRE / August 11, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Exposures Product Safety
A Bullish Outlook on Ocugen Is a Bearish Outlook on the Pandemic
For OCGN stock to justify its present valuation, Covaxin will have to generate a significant amount of North American sales. If it doesn’t the stock has a long way to fall. 
Via InvestorPlace
LAWSUITS FILED AGAINST JRVR, OCGN and LOTZ - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / August 10, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, CRMD and AHCO
NEW YORK, NY / ACCESSWIRE / August 10, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.